| a, b, c (Å) | unit cell parameters in angstroms |
| ACSc-5 | (Z)-6-methyl-N′-(4-phenylpiperazine-1-carbonothioyl) picolinohydrazonamide |
| ADME | absorption, distribution, metabolism, and excretion |
| AIDS | acquired immune deficiency syndrome |
| ATCC | American Type Culture Collection |
| CCDC | Cambridge Crystallographic Data Centre |
| Cip | ciprofloxacin |
| COVID-19 | Coronavirus Disease 2019 |
| DBU | 1,8-diazabicyclo [5.4.0]undec-7-ene |
| DMK-15 | (Z)-N′-(morpholine-4-carbonothioyl)-4-(pyrrolidin-1-yl)picolinohydrazonamide |
| DMSO-d6 | isotopologue of dimethyl sulfoxide |
| ETB | ethambutol |
| F2 | structure factor squared |
| FLEX | flexibility |
| FT-IR | Fourier-transform infrared spectroscopy |
| H37Rv | standard M. tuberculosis strain |
| HDF | human dermal fibroblast line |
| HIV | human immunodeficiency virus |
| IC50 | half-maximal inhibitory concentration |
| INH | isoniazid |
| INSATU | insaturation |
| INSOLU | insolubility |
| IR | infrared radiation |
| M. tuberculosis | Mycobacterium tuberculosis |
| MBC | minimal bactericidal concentration |
| MFC | minimal fungicidal concentration |
| MIC | minimal inhibition concentration |
| M r | molecular mass |
| NMR | nuclear magnetic resonance |
| Nys | nystatin |
| PAS | p-aminosalicylic acid |
| POLAR | polarity |
| PZA | pyrazinamide |
| R | index based on structure factors describing compatibility of the model with X-ray diffraction data |
| RMP | rifampicin |
| S | goodness of fit of the refined X-ray structure |
| Spec. 192 | strain fully sensitive to the administrated tuberculostatic drugs |
| Spec. 210 | strain isolated from tuberculosis patients resistant to PAS, INH, ETB, and RMP |
| tPSA | polarity |
| UV | ultraviolet |
| V (Å3) | volume of a unit cell in cube angstroms |
| Van | vancomycin |
| WHO | World Health Organization |
| WLOGP | lipophilicity |